NCT00188864View on ClinicalTrials.gov

Dexamethasone for Palliation - Brain Metastases

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

November 30, 2006

Study Completion Date

January 28, 2019

Conditions
Neoplasm Metastasis
Interventions
DRUG

dexamethasone

Trial Locations (1)

M5G 2M9

Princess Margaret Hospital, Toronto

All Listed Sponsors
collaborator

Princess Margaret Hospital, Canada

OTHER

lead

University Health Network, Toronto

OTHER

NCT00188864 - Dexamethasone for Palliation - Brain Metastases | Biotech Hunter | Biotech Hunter